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Influence of fecal collection 
conditions and 16S rRNA gene 
sequencing at two centers on 
human gut microbiota analysis
Jocelyn Sietsma Penington  1, Megan A. S. Penno3, Katrina M. Ngui1, Nadim J. Ajami  4, 
Alexandra J. Roth-Schulze1,2, Stephen A. Wilcox1,2, Esther Bandala-Sanchez1,2, John M. 
Wentworth1,2, Simon C. Barry3, Cheryl Y. Brown3, Jennifer J. Couper3, Joseph F. Petrosino4, 
Anthony T. Papenfuss  1,2, Leonard C. Harrison1,2 & ENDIA Study Group*
To optimise fecal sampling for reproducible analysis of the gut microbiome, we compared different 
methods of sample collection and sequencing of 16S rRNA genes at two centers. Samples 
collected from six individuals on three consecutive days were placed in commercial collection tubes 
(OMNIgeneGut OMR-200) or in sterile screw-top tubes in a home fridge or home freezer for 6–24 h, 
before transfer and storage at −80 °C. Replicate samples were shipped to centers in Australia and the 
USA for DNA extraction and sequencing by their respective PCR protocols, and analysed with the same 
bioinformatic pipeline. Variation in gut microbiome was dominated by differences between individuals. 
Minor differences in the abundance of taxa were found between collection-processing methods and 
day of collection, and between the two centers. We conclude that collection with storage and transport 
at 4 °C within 24 h is adequate for 16S rRNA analysis of the gut microbiome. Other factors including 
differences in PCR and sequencing methods account for relatively minor variation compared to 
differences between individuals.
The fecal or ‘gut’ microbiome is shaped strongly by diet but also by the host genotype, age, hygiene and antibiotic 
exposure, and is altered in many pathophysiological states1,2. The composition of gut microbiota differs greatly 
between individuals3 and therefore maximizing the detection of biological and disease-related changes requires 
minimization of variation due to methods of sample collection and analysis.
Previous studies have shown that fecal microbial composition overall was not altered when DNA was 
extracted from a fresh fecal sample compared to a sample that had been immediately frozen and stored at −80 °C 
for up to 6 months4,5. Storage at different temperatures for varying times has been compared with immediate 
freezing and storage at −80 °C. One study5 reported a decrease in Bacteroidetes and an increase in Firmicutes 
phyla after 30 minutes at room temperature, but the majority4,6–11 have found that storage at room temperature for 
at least a day, or at 4, −20 or −80 °C for up to 14 days, had little effect on the relative abundance of taxa. Moreover, 
microbial composition was not significantly altered in DNA extracted from fecal occult blood test cards that had 
been at room temperature for three days12. Recent studies have also evaluated the OMNIgene®•GUT (OMR-
200) collection and liquid storage tube, which is reported to stabilize DNA at room temperature for 14 days13. 
Samples immediately collected into these tubes and stored for three days at room temperature showed little dif-
ference in microbial composition by 16S rRNA gene sequencing compared with samples immediately frozen at 
−80 °C7. A similar result was obtained when samples in OMR-200tubes stored for 1–28 days at room temperature 
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were compared with samples from which DNA was freshly extracted14,15. However, the relative abundance of 
Bacteroides increased after seven days and in infants (who had lower microbial diversity than adults) significant 
differences from fresh samples were observed after 14 days storage.
As microbiome studies expand into larger populations at multiple sites, stringent quality control remains criti-
cal. With this in mind and to optimise analysis of the gut microbiome in a multi-site, longitudinal pregnancy-birth 
cohort study16, we evaluated the impact of different collection-processing methods on three sequential daily fecal 
samples from six individuals for 16S rRNA gene sequencing in two centers.
Methods
Six healthy adult volunteers, three males and three females aged 35–70, provided fecal samples on three successive 
days. Multiple aliquots were taken from each bulk sample and those for bacterial microbiome analysis were stored 
by one of four methods A-D (Fig. 1).
Collection-processing methods. Method A: individuals placed aliquots of feces into 6× OMNIgene®•GUT 
(OMR-200)13 tubes as per manufacturer’s protocol. These were stored at room temperature for 6–24 h before delivery 
to a laboratory for transfer to sterile 5 mL screw cap tubes and storage at −80 °C. Method B: individuals placed aliquots 
of feces into 6× sterile 5 ml screw cap tubes, which were stored in the home freezer for 6–24 h before delivery to the 
laboratory in an insulated container for storage at −80 °C. Method C: individuals placed aliquots of feces into 6× sterile 
5 m screw cap tubes, which were stored in the home refrigerator for 6–24 h before delivery to the laboratory in an insu-
lated container for storage at −80 °C. Method D: individuals placed a bulk fecal sample into a sterile 70 ml collection jar, 
which was stored in home refrigerator for 6–24 h before delivery to the laboratory in an insulated container, transfer of 
aliquots into 6× sterile 5 m screw cap tubes and storage at −80 °C.
In the laboratory, samples were handled under sterile conditions in a Biosafety Level 2 cabinet. This 
collection-processing procedure yielded a total of 432 samples (24 from each of 6 individuals per day for 3 days) 
(Fig. 1). After 2–4 weeks at −80 °C, three sample aliquots per person-day-method (n = 216) were transported 
on dry ice to sequencing centers in Australia (Walter and Eliza Hall Institute of Medical Research, Melbourne, 
Victoria; WEHI), and the USA (Baylor College of Medicine, Alkek Center for Metagenomics and Microbiome 
Research, Houston, Texas; BCM), for 16S rRNA gene amplicon sequencing. At both WEHI and BCM samples 
were stored at −80 °C for 4 weeks before sequencing.
DNA sequencing methods. Samples were thawed on ice and DNA extracted at both WEHI and BCM with 
the MoBio PowerSoil kit (MoBio Laboratories, Carlsbad, CA), as in the Human Microbiome Project17. At both 
WEHI and BCM, the V4 hypervariable region of the bacterial 16S rRNA marker gene (16Sv4) was PCR-amplified 
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Figure 1. Schematic of the four collection methods for a home-collected fecal sample. Six individuals collected 
samples over three days. Each sequencing center received three aliquots per person-day-method combination 
(216 in total).
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with primers 515F-OH1 and 806R-OH2. Analogues of these are described, respectively, by the common name 
U515F, new name S-*-Univ-0515-a-S-19, and the common name 806R, new name S-D-Bact-0787-b-A-20 in18.
At WEHI, these primers (GTGACCTATGAACTCAGGAGTCGGACTACNVGGGTWTCTAAT) and 
(CTGAGACTTGCACATCGCAGCGTGYCAGCMGCCGCGGTAA) included unique sequences (underlined) to 
provide a target for the subsequent introduction of Illumina sequencing adaptors and dual index barcodes to the ampli-
con target for paired-end sequencing on the Illumina MiSeq instrument19. Primary 16S rRNA gene PCR amplifica-
tion was performed in duplicate with the following conditions: 94 °C for 3 minutes followed by 20 cycles at 94 °C for 
45 seconds each, 55 °C for 1 minute, and 72 °C for 1 minute 30 seconds and a final extension step at 72 °C for 10 minutes. 
Successful amplification was determined by agarose gel electrophoresis. Amplicons from the primary amplification 
were diluted 1/10 and used as template for the secondary amplification. In the secondary amplification, the overhang 
sequences were used to introduce Illumina sequencing adaptors and dual index barcodes to the amplicon target. 
Individual amplicons were identified using 8 base index sequences from the Illumina Nextera design. Sixteen forward 
index primers and 24 reverse index primers were designed for a 96-well plate format with the potential to generate a 
maximum of 384 dual index amplicons. PCR conditions were as for the primary amplification, except for an increase 
to 25 cycles. Reactions were performed in triplicate in separate plates, with extra wells added, up to a maximum of 9 
wells, if PCR product appeared low. Amplicon size distribution was determined by agarose gel electrophoresis. One 
sample failed to yield sufficient product in any well. Reactions from the three replicate plates were pooled and the PCR 
amplicons purified with 1.0× NGS Beads (Macherey-Nagel). Each dual indexed library plate pool was quantified with 
the Agilent Tapestation and the Qubit™ DNR BR assay kit for Qubit 3.0® Fluorometer (Life Technologies). The indexed 
pool was diluted to 12pM and sequenced with the paired end 600-cycle (2 × 311) kit on a MiSeq instrument. After qual-
ity filtering, 702 technical replicate samples comprising 215 biological samples from the 6 individuals were obtained.
At BCM, the 16S V4 sequencing methods were adapted from the NIH-Human Microbiome Project17 and the 
Earth Microbiome Project20,21. The primers used for amplification contained adapters for MiSeq sequencing and 
single-end barcodes allowing pooling and direct sequencing of PCR products21. PCR-amplified amplicons were 
normalized by concentration before pooling and sequences were generated in one lane of a MiSeq instrument 
using the v2 kit (2 × 250 bp paired-end protocol). The 216 samples were analysed in a single pool.
Bioinformatic analysis. Sequences were clustered into operational taxonomic units (OTUs) with 97% sim-
ilarity using QIIME (Version 1.8.1)22–25, and taxonomically classified by aligning the representative sequences to 
the Greengenes 13_08 database26. Paired-end sequences were assembled with PEAR27 with parameters -v 100 -m 
600 -n 80, where -v is minimum overlap, -m is maximum assembled length and -n is minimum assembled length. 
WEHI index sequences were extracted with QIIME script extract_barcodes.py, and bases up to and including the 
533F to 805R V4 region amplicon primers were trimmed. BCM sequences were supplied as trimmed sequences 
with a separate barcode index file.
QIIME’s split_libraries_fastq.py script was used for quality filtering, with Phred quality scores required to be 
above 29, and 90% of a read’s length required to have consecutive, high-quality base calls. In order to minimize 
differences between WEHI and BCM sequences, WEHI sequences were further filtered by aligning to the SILVA 
123 16S rRNA gene database using MOTHUR v1.38.128,29 with start = 8390 and end = 17068, and by removing 
sequences that were not in this position.
QIIME’s open-reference OTU-picking was used with the Uclust algorithm22,23 to form clusters at 97% similarity. The 
representative sequences from each OTU were aligned with gaps to a reference set using QIIME’s implementation of 
PyNAST, then filtered for chimeric sequences using UChime with default settings30. After making a filtered OTU table 
with minimum count 3, and assigning taxonomy with Greengenes_13_0826, the data were analyzed in R.
WEHI data were derived from 759 (PCR-well) samples. Those with sequence counts <1000 or with descrip-
tions of PCR products as ‘None’ or ‘Very faint’ were discarded, which included all samples for individual 
55, method B, day 3, aliquot 3. OTU counts for the remaining technical replicates were summed to give 215 
biological-replicate samples.
Alpha and beta diversity and differential abundance analyses were performed in R using the Phyloseq package31 and 
DESeq232. Most analyses used 215 or 216 samples with minimum OTU size of 20; alpha diversities were calculated with 
the minimum-count = 3 OTUs with technical and biological replicates combined, giving 72 samples.
Data availability. The sequences analysed during this study are available in the ENA Short Read Archive, 
with accession PRJNA393083 (SRP116702), https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA393083. 
The OTU tables generated are available through Figshare with accession 5401594, https://figshare.com/articles/
ENDIA_microbiome_QC_OTUs_and_metadata/5401594.
Results
For the WEHI data set, library sizes after quality filtering, clustering, and combining PCR replicates ranged from 
30,000 to 250,000 sequences per sample, with a median of 67,000 (Figure S1A); sequences clustered into 12,652 
OTUs of minimum size 20. For the BCM data set, library sizes ranged from 5,000 to 56,000, with a median of 
27,000 (Figure S1B); sequences clustered into 3,675 OTUs of minimum size 20. The final number of sequences 
reflects differing sequencing and filtering protocols, including the use of multiple PCR replicates at WEHI.
Taxonomic overview. Samples were dominated at the phylum level by Bacteroidetes and Firmicutes, as 
expected. The mean summed proportion of these two phyla was 94%, varying from 71.9% to 99.7% between 
individual samples. Likewise, a single order from each of these two phyla, Bacteroidales and Clostridiales, was 
dominant, with three orders from the phylum Proteobacteria contributing another 1–2% overall (Fig. 2A,D; see 
also Figure S2).
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Alpha (α) diversity is used to characterise the richness of the microbiome and its evenness (heterogeneity) 
or distribution of proportions. Samples showed a considerable spread of α diversity (Fig. 2B,E). Samples from 
individual 66 had the lowest observed richness (number of OTUs per sample) and the lowest Inverse-Simpson 
diversity index, the latter indicating dominance by a smaller number of OTUs. This is reflected in the genera 
plots (Fig. 2A,D). In contrast, samples from individual 11 had a high observed richness but a comparatively 
low Inverse-Simpson index, consistent with the presence of a few high-abundance and multiple low-abundance 
genera.
Analysis of β diversity by non-metric multidimensional scaling (NMDS) ordination of the UniFrac distance 
showed that samples cluster strongly by individual, with marked separation between individuals (Fig. 2C,F).
Figure 2. Overview of the fecal bacterial microbiome from sequencing at WEHI (A,B,C) or BCM (D,E,F). 
(A,D) Dominant bacterial genera in fecal samples, or higher taxa where genus was not available. Bars are 
colour-coded by phyla: red Bacteroidetes, blue Firmicutes, green Proteobacteria, brown Actinobacteria, yellow 
Verrucomicrobia. (B,E) Alpha diversity within samples. Two measures are shown: observed number of OTUs 
per sample, an estimate of richness, and Inverse-Simpson index indicating the evenness of the sample. Samples 
were sub-sampled to the smallest sample size, and values are the mean of 10 random sub-samples. Boxes show 
the inter-quartile range for the four methods on three days. (C,F) Beta diversity. NMDS ordination of the 
UniFrac distance between samples, a representation of phylogenetic similarity.
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Differences between WEHI and BCM data sets. For WEHI and BCM data sets the most abundant 
phyla were similar, but the proportions of less abundant phyla and higher taxonomic resolution differed. For 
example, the mean proportion of genus Akkermansia in the order Verrucomicrobiales was greater in BCM (0.7%) 
than WEHI (0.02%). The proportion of Bacteroides was lower in some individual samples for BCM than WEHI 
(Fig. 2B; also S2).
The BCM data set yielded fewer OTUs and therefore had lower values for observed richness (Fig. 2B,E). The 
number of OTUs observed per sample was dependent on sampling depth (Figure S3); values shown are based on 
the smallest sample sizes for each of the two data sets. Richness was similar between the WEHI and BCM data 
sets, with samples from individual 66 showing the lowest alpha diversity and those from individual 44 the highest. 
For the Inverse-Simpson diversity index, which is not dependent on library size at this depth of sequencing, the 
BCM data set had a greater range of values, and a greater range for samples from some individuals. Both data 
sets had similar patterns of beta diversity between individuals (Fig. 2C,F), although the BCM data set had several 
outliers.
Initial analysis was performed separately on the WEHI and BCM datasets. For better comparison of the taxon-
omies, the bioinformatic pipeline was re-applied to a data set comprising the BCM sequences and one of the three 
WEHI technical replicates (Fig. 3). The ordination plot shows ‘batch’ effects between the two sequencing centers 
and greater between-sample differences in the BCM data set.
DESeq2 was used to make generalized linear models for the counts at phylum, order and OTU levels (Table 1). 
The model included individual ID, day and collection-processing method as factors. At the phylum level, the 
largest change was in the Verrucomicrobia. At the OTU level, 3% of OTUs were significantly different (Figure S4, 
Additional data S1). Most of the differentially abundant OTUs belonged to the orders Clostridiales (63%) and 
Bacteroidales (31%). The direction of change in OTUs was not consistent, and there were no significant differ-
ences in counts for Clostridiales and Bacteroidales between WEHI and BCM data sets.
Figure 3. Beta diversity between samples from two sequencing centers. Ordination plot of Bray-Curtis 
distances between samples, using Detrended Correspondence Analysis. Points represent samples from BCM 
and a single technical replicate from WEHI.
Phylum Base mean Log2 (fold change) Adjusted p-value Max proportion WEHI Max proportion BCM
Verrucomicrobia 39.2 −2.9 2.6 × 10−39 1.1% 5.1%
Actinobacteria 68.7 −1.5 3.5 × 10−06 3.6% 21.3%
Lentisphaerae 9.6 1.6 1.5 × 10−02 1.3% 0.3%
Order
Verrucomicrobiales (V) 38.7 −3.2 4.8 × 10−45 0.3% 5.1%
Enterobacteriales (P) 146.4 −2.0 4.3 × 10−10 8.4% 9.7%
Actinomycetales (A) 0.8 −2.0 2.4 × 10−07 0.03% 0.1%
Victivallales (L) 10.4 2.0 9.6 × 10−06 1.3% 0.3%
Bifidobacteriales (A) 44.1 −1.4 6.8 × 10−03 3.5% 20.9%
Table 1. Analysis of combined data from BCM and WEHI. Log2 (WEHI/BCM) is based on a fitted mean of the 
counts in samples as calculated by the DESeq2 package32. The maximum proportions are included for context. 
The adjusted p-value is from a Wald test with the default BH adjustment. For each order the phylum is indicated 
in brackets: A Actinobacteria, L Lentisphaerae, P Proteobacteria, V Verrucomicrobia.
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Effect of collection-processing method on taxonomic analysis. Testing of the WEHI data set for differ-
ential abundances between collection-processing methods, using DESeq2 with a design controlling for the effect of 
person and day, revealed no significant differences in counts by phylum, order or family (Table 2, Fig. 4A). Five OTUs 
(0.04% of OTUs comprising 0.2% of sequences) were different under collection-processing Method A. With the BCM 
data set, collection-processing Methods A and B were taxonomically different, with a decrease in Actinobacteria in 
Method A (Fig. 4D) and an increase in Lentisphaerae, although counts were very low (p < 0.001, Additional Table S1). 
Lentisphaerae were also increased in Method A compared with Methods C and D (p < 0.05).
Diversity varied within a sample depending on collection-processing method (Fig. 4B,E) but the effect was 
small and inconsistent. After fitting a linear model with inputs for method and individual, 20–30% of variation 
was unaccounted for, while collection-processing method accounted for only 2%. Overall, alpha diversity was 
slightly lower with Method A in the WEHI data set, and higher with Method B in the BCM dataset. (Table 3).
Different methods of collection-processing might also increase the variance between samples, reducing the repro-
ducibility of a result. Two approaches were used to test for this. Greater variance between samples is equivalent to 
greater distance between samples by some measure. The Bray-Curtis dissimilarity between OTU counts was calcu-
lated for pairs of samples from each individual and method, and a Tukey Honest Significant Difference test applied 
to a linear model of the dissimilarity. There was no evidence that the dissimilarity between samples was different for 
collection-processing methods (smallest p = 0.1) in the WEHI data set. There were significant differences in Bray-Curtis 
distances between samples in the BCM data set (p < 0.001), with collection-processing Method A associated with 
smaller differences between samples from the same individual than Methods B, C and D (Additional Table S2).
In addition, we looked for differences in the variance of the four most abundant phyla. The log transformed 
standardised counts for Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria per sample were compared 
with the mean across collection-processing methods for each individual (Fig. 4C,F). In the WEHI data set 
Methods B, C and D gave similar results, while method A had lower variance within samples from the same indi-
vidual but greater deviation from the mean compared with the other methods.
Effect of collection-processing method on library size. Collection-processing methods were com-
pared after quality filtering, barcode extraction and clustering. In the WEHI data set, the number of DNA 
sequences extracted per sample was not different by collection-processing method; in the BCM data set, 
collection-processing Method D resulted in fewer sequences than other collection-processing methods, but the 
difference was small compared with total variation (Figure S5). Batch effects (sequencing run) were more signif-
icant (p < 10−5) than collection-processing method, but batch and method together contributed less than 5% of 
the variation in library size.
Discussion
This was a quality assessment study prior to commencing a multi-site, longitudinal pregnancy-birth cohort study. 
Our main focus was the comparison of fecal sample collection and storage methods, with samples sequenced 
at two centers. Not unexpectedly, given between-center differences in DNA extraction and sequencing meth-
odologies, some differences in WEHI and BCM data sets were observed. For example, the proportions of phyla 
Verrucomicrobia and Actinobacteria, and order Enterobacteriales were increased in the BCM compared to WEHI 
data set. Although samples were transported and arrived on dry ice at both centers, covert effects of shipping and 
handling can’t be excluded.
Different collection-processing methods for fecal samples were associated with only minor differences in fecal 
microbiota derived by 16S rRNA gene sequencing. In the BCM data set Method A using the OMNIgeneGut 
OMR-200 device exhibited differences in phyla Actinobacteria and Lentisphaerae proportions compared with 
the methods that involved either immediate freezing or refrigeration. In the WEHI data set, no method was 
associated with significantly more distance between samples at the OTU level. However, in the BCM data set beta 
diversity was reduced between Method A samples compared to the other methods, possibly reflecting mitigation 
of storage and transport effects by the OMR-200 device. In WEHI data set, the log-values of proportions of the 
four dominant phyla had lower variance within samples from the same individual, but greater deviation from the 
mean, for samples collected with Method A.
In conclusion, collection-processing methods and day of collection contribute to only minor variation in fecal 
microbiome extracted sequences, composition and diversity, the major variation being at the level of the indi-
vidual. Collection with storage and transport at 4 °C within 24 h is adequate for analysis of the fecal microbiome. 
Method 
comparison
# OTUs different 
(WEHI)
# phyla different 
(BCM)
# OTUs different 
(BCM)
A-D 1 1 26
B-D 0 0 0
C-D 0 0 0
B-A 0 2 51
C-A 5 1 25
C-B 0 0 0
Table 2. Differences by collection-processing method in phyla and OTU counts (WEHI and BCM data sets). 
No collection-processing method had significantly different phyla in the WEHI data set. Wald test for absolute 
value of log2 (fold change) > 1 with Benjamini-Hochberg adjusted p-value < 0.05.
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These findings complement and support the results of several previous studies4–11. They are relevant to the qual-
ity control of gut microbiome studies, in particular to population-based multi-site studies, samples from which 
would ideally be analysed by the same methodology.
Figure 4. Effect of collection-processing method from sequencing at WEHI (A,B,C) or BCM (D,E,F). (A,D) 
Log of standardised counts (scaled by library size) of the four most abundant phyla. Points show mean and 
bars standard deviation (sd) for each individual and collection-processing method. Method A has the smallest 
average sd for Bacteroidetes and Actinobacteria. (B,E) The Inverse-Simpson α diversity index for each sample 
(compare with Fig. 2). (C,F) Mean log (standardised count) plotted against the mean over the collection-
processing methods, and a linear regression applied. Method A has the greatest average deviation from the 
linear model for the WEHI data set.
www.nature.com/scientificreports/
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